Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients

Abstract

For patients with TKI resistance, mutation and ACA screening may play a role in identifying patients with poorer prognosis.